- Ticker
- REGN
- Asset type
- Stocks
- Collections
Healthcare
Biotec
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a leading American biotechnology company that invents, develops, and commercializes life-transforming medicines for serious diseases, including eye conditions, cancer, and inflammatory disorders. Founded in 1988 and headquartered in New York, the firm utilizes proprietary technologies like VelociSuite to accelerate drug discovery and maintain a robust clinical pipeline. The company is known for major products such as Eylea and Dupixent, and it recently launched Otarmeni, the first FDA-approved gene therapy for a specific form of genetic hearing loss.
How to buy Regeneron Pharmaceuticals on Grow →
Trading hours
The following are when you can trade Regeneron Pharmaceuticals in Grow (24/5).
| Session | Hours (ET) | Tradeable |
|---|---|---|
| Pre-market | 4:00 AM–9:30 AM ET | |
| Regular | 9:30 AM–4:00 PM ET | |
| After-hours | 4:00 PM–8:00 PM ET | |
| Overnight | 8:00 PM–4:00 AM ET (next day) |
Excludes US market holidays.
Regeneron Pharmaceuticals is a tokenized asset that is backed 1:1 by the underlying security held at a licensed custodian. Learn more
